Gqerberha, 21 October 2022 – The South African Health Products Regulatory Authority (SAHPRA), as part of its awareness campaign targeting tertiary institutions, visited the Eastern Cape’s Nelson Mandela University (NMU) on Friday, the 21st of October. Human Resources (HR) and the Office of the Chief...
The South African Health Products Regulatory Authority (SAHPRA) hosted a conversation on our recent accolade of attaining the World Health Organisation (WHO) Maturity Level 3 (ML3) for vaccine production. We had invited some of our Executives, CEO Dr. Boitumelo Semete-Makokotlela, CRO Portia Nkambule, and COO Christelna...
Pretoria, 10 October 2022 – The South African Health Products Regulatory Authority (SAHPRA) hosted representatives from Germany’s Paul Ehrlich Institut’s (PEI) BloodTrain programme to discuss activities in strengthening blood and blood product regulations in Africa. SAHPRA enters this collaboration after participating in the PEI and African...
Pretoria, 10 October 2022 – The South African Health Products Regulatory Authority (SAHPRA), like other regulators globally, has been alerted to dubious health products being traded by an Indian company, Maiden Pharmaceuticals. The products as they appear on the World Health Organisation (WHO) product list (Medical...
Pretoria, 07 October 2022 – The South African Health Products Regulatory Authority (SAHPRA) hosted the African Union Development Agency (AUDA-NEPAD) as part of the African Union’s Smart Safety Surveillance (AU-3S) programme. African Union’s Smart Safety Surveillance (AU-3S) programme is aimed at strengthening the safety surveillance of...
Pretoria, 06 October 2022 – The South African Health Products Regulatory Authority (SAHPRA), as part of its awareness campaign targeting tertiary institutions, visited the University of the Witwatersrand (Wits) on Thursday, the 6th of October. Human Resources (HR) and the Inspectorate and Regulatory Compliance unit...
Pretoria, 5 October 2022 - The South African Health Products Regulatory Authority (SAHPRA) has recently been ranked by the World Health Organisation (WHO) at a functional level of maturity (Level 3) according to WHO’s global classification system for national medical products regulatory authorities. This means...
UPDATE ON COVID-19 HEALTH PRODUCTS: SAHPRA registers the Covovax COVID-19 vaccine from Cipla (Pty) Ltd and additional indication of use of COVID-19 vaccine MC Pharma from MC Pharma (Pty) Ltd in the age group 3 -17 years. Pretoria, 28 September 2022 – SAHPRA registered a COVID-19...
SAHPRA invited all local and foreign Conformity assessment bodies to a joint meeting with SANAS. The session is scheduled as follows: Download Agenda Recording below: ...
In commemoration of World Patient Safety Day and World Pharmacist Day (observed annually on 17 and 25 September, respectively), the South African Health Products Regulatory Authority (SAHPRA) hosted a Medicine Safety Webinar on 26 September 2022. The webinar focused on increasing awareness and reporting of adverse...
